14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ENDV
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Endonovo Therapeutics, Inc. stock upgraded to Hold/Accumulate.
(Updated on Jun 12, 2024)

Hold candidate since Jun 12, 2024 PDF

No changes to the price of Endonovo Therapeutics, Inc. stock on the last trading day (Wednesday, 12th Jun 2024). During the last trading day the stock fluctuated 0% from a day low at $0.0009 to a day high of $0.0009. The price has been going up and down for this period, and there has been a -10% loss for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -57.80% during the next 3 months and, with a 90% probability hold a price between $0.0003 and $0.0007 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ENDV Signals & Forecast

There are mixed signals in the stock today. The Endonovo Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0010 and $0.0016. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Monday, June 03, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Endonovo Therapeutics, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week, the stock has had daily average volatility of 13.93%.

Our recommended stop-loss: $0.0008 (-6.38%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 14 days ago.)

Trading Expectations (ENDV) For The Upcoming Trading Day Of Thursday 13th

For the upcoming trading day on Thursday, 13th we expect Endonovo Therapeutics, Inc. to open at $0.0009, and during the day (based on 14 day Average True Range), to move between $0.0006 and $0.0012, which gives a possible trading interval of +/-$0.0003 (+/-32.51%) up or down from last closing price. If Endonovo Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 65.03% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.0010, some $0.0001 (11.11%) from the current price of $0.0009, our system finds the risk reward not very attractive.

Is Endonovo Therapeutics, Inc. stock A Buy?

Endonovo Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Endonovo Therapeutics, Inc. of Thursday, June 13, 2024

Fair opening price June 13, 2024 Current price
$0.0009 ( 0.00000000%) $0.0009

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ENDV

Fibonacci Support & Resistance Levels

Level Price
R3 0.0009 0.00000000%
R2 0.0009 0.00000000%
R1 0.0009 0.00000000%
Price 0.0009
S1 0.0009 0.00000000%
S2 0.0009 0.00000000%
S3 0.0009 0.00000000%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0.0011 22.22%
R1 0.0010 11.11%
Price 0.0009
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Endonovo Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Endonovo Therapeutics, Inc. is ENDV and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Endonovo Therapeutics, Inc. Stock?
Endonovo Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Endonovo Therapeutics, Inc. Stock?
Endonovo Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Endonovo Therapeutics, Inc. Stock.

What's the current price of Endonovo Therapeutics, Inc. Stock?
As of the end of day on the Jun 12, 2024, the price of an Endonovo Therapeutics, Inc. (ENDV) share was $0.0009.

What is the 52-week high and low for Endonovo Therapeutics, Inc. Stock?
The 52-week high for Endonovo Therapeutics, Inc. Stock is $0.0178 and the 52-week low is $0.0007.

What is the market capitalization of Endonovo Therapeutics, Inc. Stock?
As of the Jun 12, 2024, the market capitalization of Endonovo Therapeutics, Inc. is 286.877K.
Click to get the best stock tips daily for free!

About Endonovo Therapeutics, Inc.

Endonovo Therapeutics. Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of inflammation, wounds, cardiova... ENDV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT